CIK: 0001595851
Total reported value
$331.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | Stock-Other | 17.53% | — | +356.00% | |
| 2 | ACAD | Acadia Pharmaceuticals INC | Stock-Healthcare | 6.31% | — | +620.00% | |
| 3 | 2655787D | Blueprint Medicines CORP | Stock-Other | 5.02% | — | — | |
| 4 | AM6 | Amicus Therapeutics INC | Stock-Other | 4.62% | — | +100.00% | |
| 5 | GBTUSD | Global Blood Therapeutics In | Stock-Other | 4.15% | — | +62.16% | |
| 6 | IMMU | Immunomedics INC | Stock-Other | 4.02% | — | -50.00% | |
| 7 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 3.84% | — | — | |
| 8 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 3.66% | — | +328.57% | |
| 9 | SG7 | Sage Therapeutics INC | Stock-Other | 3.12% | — | +125.23% | |
| 10 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 2.99% | — | -5.88% | |
| 11 | RTRXEUR | Retrophin INC | Stock-Other | 2.96% | — | — | |
| 12 | MRTXEUR | Mirati Therapeutics INC | Stock-Other | 2.87% | — | -62.50% | |
| 13 | IOVA | Iovance Biotherapeutics INC | Stock-Other | 2.86% | — | +15.00% | |
| 14 | RCKT | Rocket Pharmaceuticals INC | Stock-Other | 2.75% | — | — | |
| 15 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 2.60% | — | — | |
| 16 | BHVN | Biohaven Ltd. | Stock-Other | 2.35% | — | -36.36% | |
| 17 | PTGX | Protagonist Therapeutics INC | Stock-Other | 2.30% | — | — | |
| 18 | FXF | Invesco Currencyshares Swiss | ETF-Other | 2.24% | — | +66.30% | |
| 19 | ANAB | Anaptysbio INC | Stock-Other | 2.19% | — | -17.86% | |
| 20 | MNTA | Momenta Pharmaceuticals INC | Stock-Other | 1.90% | — | +53.85% | |
| 21 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 1.78% | — | -41.67% | |
| 22 | RARXEUR | Ra Pharmaceuticals INC | Stock-Other | 1.76% | — | — | |
| 23 | ✓ | Stock-Other | 1.71% | — | — | ||
| 24 | EPZMEUR | Epizyme INC | Stock-Other | 1.62% | — | — | |
| 25 | CHRS | Coherus Oncology INC | Stock-Other | 1.60% | — | — | |
| 26 | 1T7 | Tricida INC | Stock-Other | 1.51% | — | -40.00% | |
| 27 | KDMN | Kadmon Holdings INC | Stock-Other | 1.45% | — | +5.00% | |
| 28 | VRAYQ | Viewray INC | Stock-Other | 1.45% | — | — | |
| 29 | ORTXUSD | Orchard Therapeutics PLC | Stock-Other | 1.40% | — | — | |
| 30 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 1.15% | — | — | |
| 31 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 1.06% | — | — | |
| 32 | CHMA | Chiasma INC | Stock-Other | 0.95% | — | — | |
| 33 | ARVN | Arvinas INC | Stock-Other | 0.67% | — | — | |
| 34 | ✓ | Obseva SA | Stock-Other | 0.67% | — | -63.64% | |
| 35 | ✓ | Genocea Biosciences INC | Stock-Other | 0.31% | — | -43.26% | |
| 36 | SLDB | Solid Biosciences Inc. | Stock-Other | 0.24% | — | — | |
| 37 | ✓ | Gyre Therapeutics INC Com | Stock-Other | 0.21% | — | -50.00% | |
| 38 | FGENEUR | Fibrogen INC | Stock-Other | 0.16% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | +14.7% | +356.00% | Add |
| 2 | ACAD | Acadia Pharmaceuticals INC | +5.6% | +620.00% | Add |
| 3 | ALNY | Alnylam Pharmaceuticals INC | +2.7% | +328.57% | Add |
| 4 | AM6 | Amicus Therapeutics INC | +2.4% | +100.00% | Add |
| 5 | SG7 | Sage Therapeutics INC | +2% | +125.23% | Add |
| 6 | GBTUSD | Global Blood Therapeutics In | +1.4% | +62.16% | Add |
| 7 | MNTA | Momenta Pharmaceuticals INC | +0.6% | +53.85% | Add |
| 8 | FXF | Invesco Currencyshares Swiss | +0.3% | +66.30% | Add |
| 9 | 4XC1 | Kalvista Pharmaceuticals INC | -0.1% | -5.88% | Trim |
| 10 | KDMN | Kadmon Holdings INC | -0.1% | +5.00% | Add |
| 11 | ✓ | Genocea Biosciences INC | -0.1% | -43.26% | Trim |
| 12 | ARVN | Arvinas INC | -0.2% | — | Unchanged |
| 13 | VRAYQ | Viewray INC | -0.2% | — | Unchanged |
| 14 | ORTXUSD | Orchard Therapeutics PLC | -0.3% | — | Unchanged |
| 15 | IOVA | Iovance Biotherapeutics INC | -0.4% | +15.00% | Add |
| 16 | ✓ | Gyre Therapeutics INC Com | -0.4% | -50.00% | Trim |
| 17 | BCRX | Biocryst Pharmaceuticals INC | -0.4% | — | Unchanged |
| 18 | RCKT | Rocket Pharmaceuticals INC | -0.5% | — | Unchanged |
| 19 | BOLDEUR | Audentes Therapeutics INC | -0.5% | -41.67% | Trim |
| 20 | 1T7 | Tricida INC | -0.6% | -40.00% | Trim |
| 21 | VRTX | Vertex Pharmaceuticals INC | -1% | — | Unchanged |
| 22 | ANAB | Anaptysbio INC | -1.1% | -17.86% | Trim |
| 23 | RTRXEUR | Retrophin INC | -1.2% | — | Unchanged |
| 24 | BHVN | Biohaven Ltd. | -1.3% | -36.36% | Trim |
| 25 | ✓ | Obseva SA | -1.9% | -63.64% | Trim |
| 26 | MRTXEUR | Mirati Therapeutics INC | -3.3% | -62.50% | Trim |
| 27 | IMMU | Immunomedics INC | -4.3% | -50.00% | Trim |
| 28 | XBI | Ss Spdr S&p Biotech ETF | — | EXIT | Sold out |
| 29 | 2655787D | Blueprint Medicines CORP | — | NEW | New buy |
| 30 | DRNAUSD | Dicerna Pharmaceuticals INC | — | EXIT | Sold out |
| 31 | CBAYUSD | Cymabay Therapeutics INC | — | NEW | New buy |
| 32 | PTGX | Protagonist Therapeutics INC | — | NEW | New buy |
| 33 | SRPT | Sarepta Therapeutics INC | — | EXIT | Sold out |
| 34 | RARXEUR | Ra Pharmaceuticals INC | — | NEW | New buy |
| 35 | ✓ | — | NEW | New buy | |
| 36 | EPZMEUR | Epizyme INC | — | NEW | New buy |
| 37 | CHRS | Coherus Oncology INC | — | NEW | New buy |
| 38 | AXSM | Axsome Therapeutics INC | — | NEW | New buy |
| 39 | ZFGNUSD | Zafgen INC | — | EXIT | Sold out |
| 40 | BDSIUSD | Biodelivery Sciences Intl | — | EXIT | Sold out |
| 41 | CHMA | Chiasma INC | — | NEW | New buy |
| 42 | ✓ | Urovant Sciences LTD | — | EXIT | Sold out |
| 43 | SLDB | Solid Biosciences Inc. | — | NEW | New buy |
| 44 | ITCIEUR | Intra-cellular Therapies INC | — | EXIT | Sold out |
| 45 | FGENEUR | Fibrogen INC | — | NEW | New buy |
| 46 | PTIEUR | Proteostasis Therapeutics In | — | EXIT | Sold out |
| 47 | ✓ | Motus Gi Hldgs INC | — | EXIT | Sold out |
| 48 | MDGL | Madrigal Pharmaceuticals INC | — | EXIT | Sold out |